New patent for Novartis drug TAFINLAR

August 17, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are six patents protecting…

The post New patent for Novartis drug TAFINLAR appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.